Following the mandate given by the European Commission to the SCCS in October 2020, the Scientific Committee has just published its final Opinion on the safety of the UV-filter HAA299 (nano). It has been adopted during the Scientific Committee plenary meeting of 26-27 October 2021.
Background
HAA299 (nano) - INCI: “Bis-(Diethylaminohydroxybenzoyl Benzoyl) Piperazine” (CAS 919803-06-8) - is a cosmetic ingredient with the reported functions of UV-filter.
In its Opinion SCCS/1533/14, the SCCS concluded that “the use of non-nano HAA299 […] at a concentration up to 10% as an UV-filter in cosmetic products, does not pose a risk of systemic toxicity in humans.” But the Committee added that this “Opinion does not cover the safety evaluation of HAA299 which is composed of nano particles.””
In September 2020, a dossier was submitted requesting a safety assessment of HAA299 (nano) for use as a UV filter up to a maximum concentration of 10%.
The Scientific Committee published its preliminary Opinion in July 2021.
For an exhaustive background information, see the article
• HAA299 (nano): New request for SCCS Opinion, CosmeticOBS, 9 November 2020
• HAA299 (nano): preliminary Opinion of the SCCS, CosmeticOBS, 23 August 2021
This SCCS preliminary Opinion has been subject to a commenting period of eight weeks after its initial publication. Comments received during this time were considered by the Scientific Committee. For this Opinion, no change occurred and conclusions remain unchanged from the preliminary version.
Opinion
1. In light of the data …
